Median Technologies

ALMDT

Company Profile

  • Business description

    Median Technologies is engaged in providing medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development. The firm intends to target the oncology clinical trials market and the cancer patient care market. It developed software-based tools that are integrated into a clinical application portfolio called Lesion Management Solutions. The company has two platforms, iSee for imaging services in clinical trials and eyonis for non-invasive diagnostic tests based on imaging for the treatment of patients suffering from cancer and other chronic diseases. Geographically, the company generates revenue from EMEA, the USA/Canada, and China.

  • Contact

    1800 Route Des Cretes
    Les Deux Arcs B
    Valbonne06560
    FRA

    T: +33 493333777

    https://www.mediantechnologies.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2025

    Employees

    211

Stocks News & Analysis

stocks

Westpac earnings: Tech overhaul is costly but not hurting lending and deposit growth

Our view after latest earnings report.
stocks

Future Focus: Are franking credits ‘free alpha’?

There’s always an opportunity cost.
stocks

Berkshire Hathaway earnings: Cash balances hit $358 billion on mostly solid results across the firm

We think Berkshire Hathaway stock is moderately undervalued.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,098.2075.80-0.83%
CAC 408,109.7911.28-0.14%
DAX 4024,132.41174.110.73%
Dow JONES (US)47,336.68226.19-0.48%
FTSE 1009,701.3715.88-0.16%
HKSE25,947.19211.17-0.81%
NASDAQ23,834.72109.770.46%
Nikkei 22551,497.20914.14-1.74%
NZX 50 Index13,605.9649.660.37%
S&P 5006,851.9711.770.17%
S&P/ASX 2008,813.7069.00-0.78%
SSE Composite Index3,960.1916.33-0.41%

Market Movers